Phoenix Wealth Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-284
Closed -$23K 281
2021
Q3
$23K Hold
284
0.02% 254
2021
Q2
$26K Hold
284
0.02% 235
2021
Q1
$24K Hold
284
0.02% 244
2020
Q4
$27K Buy
+284
New +$24.8K 0.02% 235

Other funds holding NVS

Phoenix Wealth Advisors's NVS Position: Q4 2021 in Review

Phoenix Wealth Advisors sold out of Novartis (NVS) in Q4 2021, closing a stake of 284 shares — an estimated $23K sold.

Phoenix Wealth Advisors first reported a position in NVS in Q4 2020 and held it in 4 quarters. The position peaked at $27K in Q4 2020. 1,146 funds tracked by Wall St. Rank hold NVS as of Q4 2021.

  • Phoenix Wealth Advisors reported no remaining Novartis position as of Q4 2021 after selling out during the quarter.
  • Phoenix Wealth Advisors sold 284 Novartis shares in Q4 2021, an estimated $23K.
  • Phoenix Wealth Advisors first reported a position in Novartis in Q4 2020 and held it in 4 quarters.
  • Phoenix Wealth Advisors's Novartis position peaked at $27K in Q4 2020.
  • 1,146 funds tracked by Wall St. Rank held Novartis as of Q4 2021.

Based on Phoenix Wealth Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.